Medknow Publications on behalf of the Neurological Society of India
Vol. 56, No. 3, 2008, pp. 289-297
Bioline Code: ni08079
Full paper language: English
Document type: Review Article
Document available free of charge
Neurology India, Vol. 56, No. 3, 2008, pp. 289-297
© Copyright 2008 Neurology India.
Urtizberea, J. Andoni; Bassez, Guillaume; Leturcq, France; Nguyen, Karine; Krahn, Martin & Levy, Nicolas
Dysferlinopathies encompass a large variety of neuromuscular diseases characterized by the absence of dysferlin in skeletal muscle and an autosomal recessive mode of inheritance. So far, three main phenotypes have been reported: Miyoshi myopathy (MM), limb girdle muscular dystrophy type 2B (LGMD 2B), and distal myopathy with anterior tibial onset (DMAT). A growing number of clinical variants have recently been described with a much wider range of symptoms and onset. Although rare, dysferlinopathies can account for up to 30% of progressive recessive muscular dystrophies in certain geographical areas, notably in the Middle East and the Indian subcontinent. Dysferlin is a large protein involved in membrane repair and vesicle trafficking and interacts probably with important immunological pathways. New insights in its pathophysiology may result in innovative therapies in the near future.
Distal myopathy with anterior tibial onset, dysferlinopathies, dysferlin, limb girdle muscular dystrophy, LGMD 2B, Miyoshi myopathy, muscular dystrophy, mini-dysferlin
Alternative site location: http://www.neurologyindia.com